Johnson & Johnson (NYSE:JNJ) Q1 2020 Earnings Conference Call April 14, 2020 8:30 AM ET
Company Participants
Chris DelOrefice - Vice President, Investor Relations
Alex Gorsky - Chairman and Chief Executive Officer
Paul Stoffels - Vice Chairman and Chief Scientific Officer
Joe Wolk - Executive Vice President and Chief Financial Officer
Joaquin Duato - Vice Chairman
Conference Call Participants
David Lewis - Morgan Stanley
Chris Schott - JPMorgan
Larry Biegelsen - Wells Fargo
Joanne Wuensch - Citi
Terence Flynn - Goldman Sachs
Louise Chen - Cantor
Operator
Good morning. Welcome to Johnson & Johnson’s First Quarter 2020 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference call over to Johnson & Johnson. You may begin.
Chris DelOrefice
Good morning. This is Chris DelOrefice, Vice President of Investor Relations for Johnson & Johnson. Welcome to our company’s review of business results for the first quarter of 2020. I hope everyone is healthy and remaining safe during these times. With safety in mind, we are utilizing a more virtual approach in exercising social distancing while conducting this call.
Joining me on call today to address Johnson & Johnson’s response to the coronavirus global pandemic along with our first quarter results are Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer; Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer; and Joe Wolk, Executive Vice President, Chief Financial Officer. During the Q&A portion of the call, Joaquin Duato, Vice Chairman of the Executive Committee, will also join Alex, Paul, Joe and myself.
A few logistics before we get into the details. This review is being made available via webcast accessible through the Investor Relations section of the Johnson & Johnson website at investor.jnj.com where you can also find additional materials, including today’s presentation and associated schedules. We
- Read more current JNJ analysis and news
- View all earnings call transcripts